To Advance Animal-Model ECG Labeling with MaxYield™.
Toronto, ON – October 29, 2026 – AI/ML Innovations Inc. (“AIML” or the “Company”) (CSE: AIML; OTCQB: AIMLF; FWB: 42FB), a company advancing artificial intelligence and neural-network-based technologies for digital health, is pleased to announce that its wholly owned subsidiary, NeuralCloud Solutions Inc. (“NeuralCloud”), has entered into an agreement dated October 27, 2026 (the “Agreement”) with Etisense SAS (“Etisense”), a Lyon, France-based life sciences technology company specializing in non-invasive wearable telemetry and data analysis software for preclinical research.
